Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.04. | Careium appoints Joe McLoughlin as the Regional Managing Director in the UK | 1 | Cision News | ||
28.03. | Careium publishes Annual report with Sustainability report 2023 | 1 | Cision News | ||
29.01. | Invitation to presentation of Careium's 2023 Year-end report | 1 | Cision News | ||
18.01. | Careium welcomes Q Technology Group as a shareholder | 1 | Cision News | ||
17.11.23 | Careium ranked as number one on substantial UK framework | 1 | Cision News | ||
02.11.23 | Careium implements organisational changes for stronger commercial development and changes the management of its Swedish operations. | 1 | Cision News | ||
30.10.23 | Careium strengthens the Supply Chain and IT organisation through recruitment and reorganisation, which also involves changes in the group management. | 2 | Cision News |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 27,180 | -0,51 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 52,30 | -0,87 % | DAX & Co: Sartorius, Netflix, Siemens Healthineers, LVMH, Aixtron und Rheinmetall im Fokus | Der DAX hat am Mittwoch seine Gewinne bis zum Handelsende wieder vollständig abgegeben. Am Ende ging er mit einem Plus von 0,02 Prozent auf 17.770,02 Zähler über die Ziellinie. Am heutigen Donnerstag... ► Artikel lesen | |
THERMO FISHER | 534,00 | -1,07 % | Q1-Zahlen überzeugen: Starke Nachfrage: Thermo Fisher hebt Gewinnprognose an | © Foto: © Copyright 2024 Thermo Fisher ScientificThermo Fisher Scientific hat die Quartalserwartungen der Wall Street übertroffen und seine Jahresgewinnprognose nach oben korrigiert.Die Aktien des Medizingeräteherstellers... ► Artikel lesen | |
EUROFINS SCIENTIFIC | 57,28 | +0,35 % | Eurofins Scientific SE: Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives | Regulatory News:
The Eurofins (Paris:ERF) network of companies continues to deliver resilient growth:
Reported revenues in Q1 2024 totalled €1,653m, an increase of 5.0% vs Q1 2023, driven... ► Artikel lesen | |
SYNLAB | 10,500 | -0,38 % | Synlab wird in Italien Opfer von Hackerattacke | Die Serie von Hackerattacken gegen börsennotierte Unternehmen geht weiter. Zuletzt hatte unter anderem Varta einen entsprechenden Angriff mit deutlichen Auswirkungen auf das Geschäft gemeldet, nun meldet... ► Artikel lesen | |
DAVITA | 124,00 | -0,08 % | DaVita Set To Achieve 100% Renewable Energy Consumption Goal By 2025 | WASHINGTON (dpa-AFX) - Kidney care services provider DaVita (DVA) said Monday it expects to match 100% of its electricity use across its global operations with renewable energy purchases by... ► Artikel lesen | |
DENTSPLY SIRONA | 28,380 | -1,77 % | A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 Analysts | ||
SMITH & NEPHEW | 11,560 | -0,17 % | Smith & Nephew UK Ltd: Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention | Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group... ► Artikel lesen | |
SONIC HEALTHCARE | 16,150 | -0,60 % | SONIC HEALTHCARE LIMITED: Change in substantial holding | ||
DIASORIN | 95,30 | -0,79 % | DiaSorin jumps after BofA restarts with 'buy' rating | ||
FULGENT GENETICS | 18,700 | -3,61 % | Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
PATTERSON COMPANIES | 23,800 | -3,25 % | Dividendenbekanntmachungen (18.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 0,5706 USD 0,5347 EUR AKER ASA NO0010234552 15,5 NOK 1,3202 EUR ANORA GROUP OYJ FI4000292438 - 0... ► Artikel lesen | |
IMPLANTICA | 2,280 | -2,98 % | Implantica submits U.S. FDA Premarket Approval (PMA) application for RefluxStop® (first module) | VADUZ, Liechtenstein, March 27, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces the submission of the... ► Artikel lesen | |
PERSPECTIVE THERAPEUTICS | 1,500 | -3,23 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results | SEATTLE, March 28, 2024 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout... ► Artikel lesen | |
OMNICELL | 25,400 | -1,55 % | Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen |